Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.
Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB.
Murray SE, et al. Among authors: hill ab.
J Exp Med. 2017 Jul 3;214(7):1889-1899. doi: 10.1084/jem.20161988. Epub 2017 May 31.
J Exp Med. 2017.
PMID: 28566275
Free PMC article.
Clinical Trial.